AITIA

Welcome to the Brand page for “AITIA”, which is offered here for Licensing of intellectual property;providing temporary use of non-downloadable cloud-based software for simulating and modeling an in silico patient; providing computer modeling services, in silico modeling of disease progression, drug response and simulating combo therapies in the fields of oncology, immunology, neurodegeneration, cardiometabolic disease, rare diseases, infectious diseases, and blood diseases; consulting services for others in the field of computer modeling of oncology, immunology, neurodegeneration, cardiometabolic disease, rare diseases, infectious diseases, blood diseases, and translational medicine for use in clinical trial design and pharmaceutical drug development; clinical trial design services; providing medical and scientific research information in the fields of artificial intelligence, clinical trials, and translational medicine; software as a service (saas) services featuring software for using artificial intelligence for collecting, analyzing, interpreting and reporting data and information in the field of drug discovery and development; platform as a service (paas) featuring computer software platforms for using artificial intelligence for collecting, analyzing, interpreting and reporting data and information in the field of drug discovery and development; scientific and medical research services in the fields of artificial intelligence, clinical trials, and translational medicine; drug discovery services;.

Its status is currently believed to be active. Its class is unavailable. “AITIA” is believed to be currently owned by “GNS Healthcare, Inc.”